Voice your opinion on congressional bill HR2565-117 and let lawmakers know your stance with UnPac!

Main Subject: Health

FDA Modernization Act of 2021

This bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug's safety and effectiveness. Under this bill, these alternative methods may include cell-based assays, organ chips and microphysiological systems, sophisticated computer modeling, and other human biology-based test methods.

House committee actions Actions

Committee
Apr. 16 2021	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral
Apr. 15 2021	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
Apr. 15 2021	Introduced in House Introduced in House

House bill HR2565-117

FDA Modernization Act of 2021

Promote the cause!

Or use this QR code